Form 4: FactSet Director Sells Shares After Option Exercise
Insider Transaction Report
FactSet Research Systems Director Malcolm Frank exercised stock options and subsequently sold a portion of his common stock holdings.
Summary
- Malcolm Frank, a Director at FactSet Research Systems Inc. (FDS), engaged in transactions on January 12, 2026.
- He exercised 2,572 non-employee director stock options at an exercise price of $207.88 per share.
- Following the option exercise, he sold 1,045 shares of common stock at a weighted average price of $295.02 per share.
- He also sold an additional 1,527 shares of common stock at a weighted average price of $296.17 per share.
- These transactions were executed pursuant to a Rule 10b5-1 pre-arranged trading plan.
- After these transactions, Malcolm Frank beneficially owns 879 shares of FactSet common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it involves insider selling, it's a pre-planned transaction under a 10b5-1 plan, often for diversification or liquidity, and not necessarily indicative of a negative view on the company's future. The director also profited from the option exercise.
Positives
- The transactions were conducted under a Rule 10b5-1 plan, indicating pre-planned sales rather than a reaction to new, non-public information.
- The exercise price of the options ($207.88) is significantly lower than the sale prices ($295.02 and $296.17), indicating a profitable transaction for the director.
Negatives
- A director selling a significant portion of their shares (2,572 shares sold out of 2,572 acquired from options, plus some existing shares) could be interpreted negatively by some investors, even if pre-planned.
- The beneficial ownership of common stock decreased from 3,451 shares to 879 shares after the transactions.
Future Outlook
NA
Industry Context
This is a routine insider transaction and does not inherently relate to broader industry trends. It reflects an individual director's portfolio management.
Stakeholder Impact
- Shareholders: Could be viewed neutrally to slightly negatively due to insider selling, but mitigated by the 10b5-1 plan and the fact it's an option exercise and sell-to-cover/diversify.
Key Dates
| Date | Description |
|---|---|
| 2022-01-15 | Grant date of the non-qualified stock options. |
| 2025-08-20 | Date Malcolm Frank executed the Power of Attorney for Section 16 filings. |
| 2026-01-12 | Date of stock option exercise and subsequent common stock sales. |
| 2026-01-14 | Date the Form 4 was signed by the attorney-in-fact. |
| 2026-01-15 | Expiration date of the non-qualified stock options. |
Recommendation
holdThe filing details a routine insider transaction where a director exercised stock options and subsequently sold shares under a pre-arranged 10b5-1 plan. This type of transaction is common for diversification and liquidity purposes and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Therefore, a 'hold' recommendation is appropriate.
Keywords
FactSet Research Systems, FDS, Malcolm Frank, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.